Adeno Associated Viral Vector Market Size, Share, Trends by 2035
The new market report titled ‘Adeno Associated Viral Vector Market,’ published by Roots Analysis is one of the most sought-after solutions for businesses operating in the Adeno Associated Viral Vector Market.

The report will help readers stay updated with the latest market trends and maintain their competitive outlooks in the modern-day fast-paced business environment. The report comes with a concise summary of the details regarding the historical market data, current market trends, future growth prospects, product landscape, key marketing strategies, technological progress, as well as the emerging market trends and opportunities. The Adeno Associated Viral Vector Market is anticipated to expand significantly. However, the latest report is mainly intended for readers interested in this specific business space and is available in the forms of PDF and spreadsheet.
To understand the complete structure of the report, get its PDF sample copy
https://www.rootsanalysis.com/....reports/adeno-associ
Adeno Associated Viral Vector Market Characterization:
Market Scope and Market Size:
The Adeno Associated Viral Vector market is broadly segmented on the basis of product type and application. The segmental growth helps the reader get a lucid picture of the niche pockets of growth, as well as the strategies deployed by the market players to drive the growth of these segments. This section of the report helps them understand and determine the core application areas and the differences between the target markets. The report scrutinizes the Adeno Associated Viral Vector market in terms of market size & volume and significant information pertaining to product bifurcation and application overview.
Key Market Contenders:
This particular section of the report covers all the necessary details of the renowned market players operating in the Adeno Associated Viral Vector market. The report goes on to elucidate various marketing strategies employed by companies across this industry. Information on the shareholdings of these players in the global market has also been included in this report. Moreover, the document presents a detailed account of the market size based on geographical segmentation. It also covers the product portfolio, their application landscape, and sales and revenue predictions of the regional fragments of the global market.
The section of this report focusing on the competitive terrain of the Adeno Associated Viral Vector market endows the reader with every significant detail and information about the leading competitors on the market. The report provides an exhaustive study and accurate statistics on revenue (on both global and regional levels) related to the prevalent competition in the market. The report offers additional details on this fundamental market segment, including major businesses, company description, total revenue & sales, recent developments, latest product launches, and revenue accumulated by these players over the forecast period.
Main chapters covered in this report:
Part 01: Market Overview
Part 02: Market Size, by regions
Part 03: Market Revenue, by countries
Part 04: Market Competition, by key players
Part 05: Company Profiles
To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/adeno-associ

You may also be interested in the following titles:
Oral Proteins and Peptides Market
Single-Use Upstream Bioprocessing Technology / Equipment Market

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#adenoassociatedviralvectormarkettrends #adenoassociatedviralvectorindustryanalysis #adenoassociatedviralvectormarketforecast #adenoassociatedviralvectormarketgrowthanalysis

Novel Antibody Therapies Market Growth Opportunity and Industry Forecast to 2035 | #radioimmunoconjugate. Immunocytokines. novel antibodies. novel antibody therapy. Market Research # Market Insight

News and Politics

Novel Antibody Therapies Market Growth Opportunity and Industry Forecast to 2035

Given the potential of novel antibody therapies in the treatment of oncological disorders, there is a growing interest in evaluating such therapy candidates against other life-threatening disease indications as well

Genotoxicity Testing and Mutagenicity Testing Services Market Trends, Analysis by 2035

Genotoxicity refers to the evaluation of detrimental effects of chemical or physical agents on the genetic processes and related hereditary material of living cells.

During our research, we were able to identify the presence of more than 80 players that are engaged in offering services across the globe.

Majority of the genotoxicity / mutagenicity testing service providers (40%) engaged in this domain were established pre-1991. This is indicative of the growing interest of stakeholders in this domain. Examples of recently established companies include (post-2010, in alphabetical order) Admescope (2011), Anax Laboratories (2012) and Aragen Life Sciences (2021). Additionally, 14% companies have entered this domain between 1991 and 2000, indicating that the market is driven by efforts of well-established players as well. At present, more than 80 players offer a variety of assays, such as Ames assay, micronucleus assay, chromosomal aberration test, genetic mutation assay and comet assay, which can be used to evaluate the genetic toxicity of a substance.

To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/....reports/genotoxicity

Further, it was observed that majority of service providers are based in Asia-Pacific (49%), followed by players based in North America (30%) and Europe (21%). The current market landscape is dominated by the presence of mid-sized organization (43%). Notable examples include (in alphabetical order) Anax Laboratories and CSIR – Indian Institute of Toxicology.

Further, genotoxicity / mutagenicity testing service providers, focuses on providing services to a wide range of industries, primarily includes healthcare industry (96%) followed by chemical industry (46%). It is worth noting that organizations such as Cadila Pharmaceuticals and DigilanceBio offer services for all types of industries.

According to our proprietary scoring criteria, in North America, Crown Biosciences has emerged to be relatively superior, in terms of company strength. The firm offer service through in vivo type of assay.

Further, Charles River Laboratories emerged as one of the prominent player offering both in vivo and in vitro assays. The platform has capability to offer services through different assay(s) / test(s) including Ames Test, micronucleus test, chromosomal aberration test, genetic mutation test and comet assay.


For additional details, please visit https://www.rootsanalysis.com/....reports/genotoxicity

You may also be interested in the following titles:

1. Quantum Computing in Drug Discovery Services Market : - Industry Trends and Global Forecasts, 2023-2035
2. Viral Clearance and Viral Testing Services Market : - Industry Trends and Global Forecasts, 2023-2035



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

The global monkeypox therapeutics and vaccines market and global monkeypox diagnostic kits market is likely to grow at a healthy pace in the foreseen future

The recent rise in the incidence of the monkeypox disease, also known as Mpox, has compelled both industry players and regional government authorities to undertake active initiatives in order to control the spread of the disease

Roots Analysis is pleased to announce the publication of its recent study, titled, “Monkeypox Market: Focus on Therapeutics, Vaccines and Diagnostic Kits, 2023-2035”

The study features an extensive study of the current market landscape and future opportunity for the players focused on the development of monkeypox therapeutics, vaccines and diagnostic kits.

To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/....reports/monkeypox-tr

Amongst other elements, the report features:
 A general introduction to monkeypox virus, along with information on signs and symptoms of the disease, history of monkeypox outbreaks and details on transmission of disease from animals to humans and humans to humans.
 A detailed assessment of the current market landscape of monkeypox therapeutics / vaccines that are approved / under development, based on several relevant parameters.
 A detailed assessment of the current market landscape of monkeypox diagnostic kits, based on several relevant parameters.
 A product competitiveness analysis of the monkeypox diagnostic kits, based on supplier power and product competitiveness.
 Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in monkeypox therapeutics / vaccines and diagnostic kits domain.
 An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2018-2022 (till October).
 An in-depth analysis on various grants, received since the year 2003, by players engaged in this field.
 A detailed analysis of more than 200 peer-reviewed, scientific articles related to research on monkeypox therapeutics / vaccines and diagnostic kits, during the period of 2018-2022 (till September).
 A qualitative analysis to understand the five competitive forces under an insightful Porter's Five Forces framework.
 More than 165 diagnostic kits are currently available in the market for the detection of monkeypox virus; these kits utilize various detection methods for monkeypox diagnosis
 Presently, more than 25 therapeutics and vaccines are either marketed or under preclinical / clinical development for the treatment and prevention of monkeypox disease.
 A detailed market forecast for monkeypox therapeutics / vaccines and diagnostic kits, featuring analysis of the current and projected future opportunity across key market segments (listed below):
 Type of Product
 Therapeutics
 Vaccines

 Developer
 Bavarian Nordic
 Emergent BioSolutions
 KM Biologics
 SIGA Technologies

 Type of Kit
 Polymerase Chain Reaction (PCR) Detection Kits
 Antigen Detection Kits
 Antibody Detection Kits

 Type of End User
 Hospitals and Clinics
 Diagnostic Laboratories
 Other End Users
 Key Geographical Regions
 North America (US and Canada)
 Europe (UK, France, Germany, Spain, Italy, Rest of EU)
 Asia-Pacific (Japan and Australia)
 Rest of the World

 Transcripts of interviews held with the following senior level representatives of stakeholder companies:
 Willy Tozoke Laou Man Cheong (Business Director, Hunan Runmei Gene Technology)
 John W Sharkey (Vice President, Business Development, GeoVax)
 Horace Lee (Sales Manager, Firegene)
 Alan Yu (Sales Manager, Hangzhou Testsea Biotechnology)

Key companies covered in the report
 Bavarian Nordic
 Emergent BioSolutions
 ACON Laboratories
 altona Diagnostics
 DNA Software
 Elabscience
 Goldsite Diagnostics
 Hangzhou Testsea Biotechnology
 Jiangsu Bioperfectus Technologies
 Lansion Biotechnology

For additional details, please visit https://www.rootsanalysis.com/....reports/monkeypox-tr
You may also be interested in the following titles:

1. Quantum Computing in Drug Discovery Services Market : - Industry Trends and Global Forecasts, 2023-2035
2. Viral Clearance and Viral Testing Services Market : - Industry Trends and Global Forecasts, 2023-2035



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

The TIL-based therapy market is projected to grow at an annualized rate of 40%, claims Roots Analysis

Owing to their tumor-killing capability and therapeutic superiority to conventional therapies, TIL-based therapies are being actively evaluated to treat advance, incurable oncological disorders by various researchers and industry stakeholders.

Roots Analysis has announced the addition of “Global TIL-based Therapy Market (2nd Edition), 2023-2035” report to its list of offerings.
Given the limitations associated with conventional cancer treatment options, there has been a surge in the need for more effective, safe and versatile alternatives, such as TIL-based therapies. Driven by a promising development pipeline and encouraging clinical trial results, the tumor infiltrating lymphocytes therapies market is likely to carve out a significant share of the cancer immunotherapy market.

Key Market Insights
Over 75 TIL-based therapies are currently approved / under development
Close to 83% of the TIL-based therapies are being evaluated in clinical trials (phase I and above), while 17% of them are in preclinical stage of development. More than 95% of the therapy candidates, which are being developed to target a range of disease indications, are autologous in nature. Further, more than 75% of these are combination therapies.

More than 3,800 patients have been enrolled in nearly 95 clinical trials, worldwide
Clinical research activity, in terms of number of trials registered, is reported to have increased over the last five years. Of the total number of trials, over 65% are active and still recruiting patients, while more than 25% have already been completed.

Partnership activity within this domain has grown at a CAGR of 29%, between 2015 and 2021
Majority of the agreements related to TIL-based therapies were observed to be R&D agreements, representing close to 40% of the total partnerships. Further, most of the intercontinental, as well as intracontinental, deals have been inked by players based in North America.

Over 2.7 USD billion has been invested by both private and public investors in this domain, since 2013
Industry players raised over USD 1.4 billion in the past 3 years. In addition, majority (37%) of the companies received funding through secondary offering rounds. Further, close to USD 540 million were invested by private firms.

More than 160 patents have been filed / published related to the TCR-based therapies
Close to 75% of the filed / published patents were patent applications, followed by granted patents (25%). Of the total granted applications, more than 95% were filed in North America.

The TIL market is anticipated to grow at a CAGR of 40%, during the period 2022-2035
In 2035, more than 50% of the market revenues are expected to be generated from sales of therapeutics intended for Melanoma. Further, North America and Europe is anticipated to capture close to 90% of the market share, by 2035.

To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/....reports/til-therapie

Key Questions Answered
 What is the growth rate of TIL-based therapy market?
 Which region has the highest growth rate in the TIL Therapies market?
 How many players are developing TIL-based Therapies?
 Which target indication covers the largest TIL-based therapy market share?
 What is the partnership and collaboration trend in the TIL-based therapy domain?
 What is the current IP landscape of TIL-based therapies market?

The financial opportunity within the TIL-based therapies market has been analyzed across the following segments:
 Target Indication(s)
 Melanoma
 Head and Neck Carcinoma
 Chronic Lymphocytic Leukemia
 Sarcoma
 Hepatocellular Carcinoma
 Breast Cancer
 Acute Myeloid Leukemia
 Cervical Carcinoma

 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Latin America
 Middle East and North Africa
 Rest of the World

The report includes brief profiles of key players (listed below); each profile features an overview of the company, details related to its financial information (if available), details about TIL-based product(s), such as information on status of development, technology portfolio (if available), recent developments related to TIL-based therapies and manufacturing capabilities of the players.
 Cellectis
 Cellular Biomedicine Group
 Iovance Biotherapeutics
 Lytix Biopharma
 Phio Pharmaceuticals

For additional details, please visit https://www.rootsanalysis.com/....reports/til-therapie or email sales@rootsanalysis.com

You may also be interested in the following titles:
1. Smart Labels Market: Industry Trends and Global Forecasts, 2022-2035
2. AI-based Digital Pathology / AI Pathology Market: Industry Trends and Global Forecasts, 2022-2035

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com